PRESS RELEASE published on 09/18/2024 at 07:30, 1 year 11 months ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report Sensorion reports 2024 first half results including progress on SENS-501 and SENS-401 programs. Cash position strong at €87m. Future milestones and financial highlights outlined Sensorion Hearing Loss SENS-401 SENS-501 2024 Results
BRIEF published on 09/12/2024 at 07:35, 1 year 11 months ago Sensorion to Present at 59th Inner Ear Biology Workshop Conference Sensorion Hearing Loss Inner Ear Biology Proteomics
PRESS RELEASE published on 09/12/2024 at 07:30, 1 year 11 months ago Inside Information / Other news releases Sensorion announces participation in the 59th Annual Inner Ear Biology Workshop in Warsaw, Poland. Presentation on SENS-401 and gene therapy programs Gene Therapy Sensorion Hearing Loss SENS-401 Inner Ear Biology Workshop
BRIEF published on 09/02/2024 at 07:35, 1 year 11 months ago Sensorion at the World Congress of Audiology 2024 in Paris Gene Therapy Sensorion Hearing Loss World Congress Of Audiology Medical Symposium
PRESS RELEASE published on 09/02/2024 at 07:30, 1 year 11 months ago Inside Information / Other news releases Sensorion to lead symposium on medical advances in hearing loss at World Congress of Audiology in Paris, September 2024 Sensorion Hearing Loss Symposium World Congress Of Audiology Medical Advances
BRIEF published on 08/05/2024 at 07:35, 2 years ago Sensorion to Participate in Stifel's Biotech Summer Summit Investment Gene Therapy Sensorion Hearing Loss Biotech Summit 2024
PRESS RELEASE published on 08/05/2024 at 07:30, 2 years ago Inside Information / Other news releases Sensorion to participate in Stifel's Biotech Summer Summit 2024 to discuss strategic developments and gene therapy programs for hearing loss disorders Gene Therapy Sensorion Hearing Loss Disorders Stifel Biotech Summer Summit
BRIEF published on 06/27/2024 at 07:35, 2 years 1 month ago Sensorion Announces Appointment of New Chief Financial Officer Chief Financial Officer Biotechnology Sensorion Hearing Loss Laurene Danon
PRESS RELEASE published on 06/27/2024 at 07:30, 2 years 1 month ago Inside Information / Other news releases Sensorion appoints Laurene Danon as Chief Financial Officer, bringing 15 years of experience in investment banking. The company focuses on developing therapies for hearing loss disorders Chief Financial Officer Investment Banking Sensorion Laurene Danon Hearing Loss Therapies
BRIEF published on 05/30/2024 at 07:35, 2 years 2 months ago Sensorion announces the results of its Combined General Meeting Biotechnology Resolutions General Assembly Sensorion Hearing Therapies
Published on 08/19/2026 at 04:00, 1 hour 54 minutes ago Momenta, XHEART, and QNX Build an Autonomous Driving Platform Certified to Global Safety Standards
Published on 08/18/2026 at 23:10, 6 hours 44 minutes ago Secure Blockchain Signs Agreement to Sell Delivery Trust(R) Business
Published on 08/18/2026 at 19:45, 10 hours 9 minutes ago ECC Ventures 5 Corp. Enters Into Business Combination Agreement with Bayrock Resources for Qualifying Transaction
Published on 08/18/2026 at 18:30, 11 hours 24 minutes ago Sterling Metals Announces Approval of Arrangement by QcX Gold Shareholders
Published on 08/18/2026 at 17:40, 12 hours 14 minutes ago Largo Physical Vanadium Announces Postponement of Annual Meeting
Published on 08/18/2026 at 22:00, 7 hours 53 minutes ago Enlight Research publishes updated coverage on Eleving Group
Published on 08/18/2026 at 21:50, 8 hours 3 minutes ago Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited
Published on 08/18/2026 at 19:00, 10 hours 53 minutes ago HIAG strengthens sustainable financing with third green bond worth CHF 100 million
Published on 08/18/2026 at 18:45, 11 hours 8 minutes ago Information about Mr. Svetlin Todorov‘s shareholdings in Shelly Group SE
Published on 08/18/2026 at 18:10, 11 hours 43 minutes ago Cumulus Neuroscience Announces Publication in Scientific Reports Demonstrating the NeuLogiq® Platform Is Feasible and Usable for At-Home, Multimodal Cognitive Assessment in People Living with ALS and FTD
Published on 08/18/2026 at 11:15, 18 hours 38 minutes ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 1 day 10 hours ago Aéroports de Paris S.A - July 2026 traffic figures
Published on 08/17/2026 at 08:33, 1 day 21 hours ago Covivio - Information on Treasury shares transactions between August 10th, 2026 and August 11th, 2026
Published on 08/17/2026 at 07:30, 1 day 22 hours ago Disclosure of transactions in own shares from August 10 to August 14, 2026
